These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 38397015)

  • 1. Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes.
    Vilariño-García T; Polonio-González ML; Pérez-Pérez A; Ribalta J; Arrieta F; Aguilar M; Obaya JC; Gimeno-Orna JA; Iglesias P; Navarro J; Durán S; Pedro-Botet J; Sánchez-Margalet V
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Leptin in Cardiovascular Diseases.
    Poetsch MS; Strano A; Guan K
    Front Endocrinol (Lausanne); 2020; 11():354. PubMed ID: 32655492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin and the clinical cardiovascular risk.
    Singh M; Bedi US; Singh PP; Arora R; Khosla S
    Int J Cardiol; 2010 Apr; 140(3):266-71. PubMed ID: 19944469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
    Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
    Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Serum TNF-
    Alzamil H
    J Obes; 2020; 2020():5076858. PubMed ID: 32089876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.
    Martin SS; Qasim A; Reilly MP
    J Am Coll Cardiol; 2008 Oct; 52(15):1201-10. PubMed ID: 18926322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between periodontitis and systemic diseases: leptin, a new biomarker?
    Jain H; Mulay S
    Indian J Dent Res; 2014; 25(5):657-61. PubMed ID: 25511069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient Leptin Cellular Signaling Plays a Key Role in Brain Ultrastructural Remodeling in Obesity and Type 2 Diabetes Mellitus.
    Hayden MR; Banks WA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin, a mediator of cardiac damage associated with obesity.
    Martínez-Martínez E; Jurado-López R; Cervantes-Escalera P; Cachofeiro V; Miana M
    Horm Mol Biol Clin Investig; 2014 Apr; 18(1):3-14. PubMed ID: 25389996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.
    Mao Y; Zhao K; Li P; Sheng Y
    Mol Cell Biochem; 2023 May; 478(5):991-1011. PubMed ID: 36214893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.
    Montagnana M; Fava C; Targher G; Franchini M; Danese E; Bonafini S; De Cata A; Salvagno GL; Ruzzenente O; Guidi GC; Lippi G
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27470535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lep Expression and Its Role in Obesity and Type-2 Diabetes.
    Qadir MI; Ahmed Z
    Crit Rev Eukaryot Gene Expr; 2017; 27(1):47-51. PubMed ID: 28436331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin as a Mediator of Obesity-Induced Hypertension.
    Bell BB; Rahmouni K
    Curr Obes Rep; 2016 Dec; 5(4):397-404. PubMed ID: 27665107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
    Diamant M
    Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention.
    Muzurović E; Dragnić S; Medenica S; Smolović B; Bulajić P; Mikhailidis DP
    J Diabetes Complications; 2020 Aug; 34(8):107619. PubMed ID: 32499116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases.
    Peelman F; Waelput W; Iserentant H; Lavens D; Eyckerman S; Zabeau L; Tavernier J
    Prog Lipid Res; 2004 Jul; 43(4):283-301. PubMed ID: 15234549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
    López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
    Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.